BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29282904)

  • 1. Human T cell responses to Dengue and Zika virus infection compared to Dengue/Zika coinfection.
    Badolato-Corrêa J; Sánchez-Arcila JC; Alves de Souza TM; Santos Barbosa L; Conrado Guerra Nunes P; da Rocha Queiroz Lima M; Gandini M; Bispo de Filippis AM; Venâncio da Cunha R; Leal de Azeredo E; de-Oliveira-Pinto LM
    Immun Inflamm Dis; 2018 Jun; 6(2):194-206. PubMed ID: 29282904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.
    Grifoni A; Pham J; Sidney J; O'Rourke PH; Paul S; Peters B; Martini SR; de Silva AD; Ricciardi MJ; Magnani DM; Silveira CGT; Maestri A; Costa PR; de-Oliveira-Pinto LM; de Azeredo EL; Damasco PV; Phillips E; Mallal S; de Silva AM; Collins M; Durbin A; Diehl SA; Cerpas C; Balmaseda A; Kuan G; Coloma J; Harris E; Crowe JE; Stone M; Norris PJ; Busch M; Vivanco-Cid H; Cox J; Graham BS; Ledgerwood JE; Turtle L; Solomon T; Kallas EG; Watkins DI; Weiskopf D; Sette A
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4
    Wen J; Wang YT; Valentine KM; Dos Santos Alves RP; Xu Z; Regla-Nava JA; Ngono AE; Young MP; Ferreira LCS; Shresta S
    Cell Rep; 2020 Apr; 31(4):107566. PubMed ID: 32348763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue Virus Immune Mothers of Congenital Zika Virus Syndrome Infants.
    Reynolds CJ; Watber P; Santos CNO; Ribeiro DR; Alves JC; Fonseca ABL; Bispo AJB; Porto RLS; Bokea K; de Jesus AMR; de Almeida RP; Boyton RJ; Altmann DM
    Front Immunol; 2020; 11():185. PubMed ID: 32132999
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous Coinfection of Macaques with Zika and Dengue Viruses Does not Enhance Acute Plasma Viremia but Leads to Activation of Monocyte Subsets and Biphasic Release of Pro-inflammatory Cytokines.
    Valiant WG; Mattapallil MJ; Higgs S; Huang YS; Vanlandingham DL; Lewis MG; Mattapallil JJ
    Sci Rep; 2019 May; 9(1):7877. PubMed ID: 31133721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests.
    Tsai WY; Youn HH; Brites C; Tsai JJ; Tyson J; Pedroso C; Drexler JF; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
    Clin Infect Dis; 2017 Nov; 65(11):1829-1836. PubMed ID: 29020159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans.
    Delgado FG; Torres KI; Castellanos JE; Romero-Sánchez C; Simon-Lorière E; Sakuntabhai A; Roth C
    Viruses; 2018 Sep; 10(9):. PubMed ID: 30205518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELISPOT-Based "Multi-Color FluoroSpot" to Study Type-Specific and Cross-Reactive Responses in Memory B Cells after Dengue and Zika Virus Infections.
    Andrade P; Coloma J; Harris E
    Methods Mol Biol; 2018; 1808():151-163. PubMed ID: 29956181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection.
    Valiant WG; Huang YS; Vanlandingham DL; Higgs S; Lewis MG; Mattapallil JJ
    Emerg Microbes Infect; 2018 Jul; 7(1):130. PubMed ID: 30006514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T Cell Responses to Nonstructural Protein 3 Distinguish Infections by Dengue and Zika Viruses.
    Herrera BB; Tsai WY; Brites C; Luz E; Pedroso C; Drexler JF; Wang WK; Kanki PJ
    mBio; 2018 Aug; 9(4):. PubMed ID: 30087165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-existing T Cell Memory against Zika Virus.
    Schouest B; Grifoni A; Pham J; Mateus J; Sydney J; Brien JD; De Silva AD; Balmaseda A; Harris E; Sette A; Weiskopf D
    J Virol; 2021 May; 95(12):. PubMed ID: 33789994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa.
    Herrera BB; Tsai WY; Chang CA; Hamel DJ; Wang WK; Lu Y; Mboup S; Kanki PJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time elapsed between Zika and dengue virus infections affects antibody and T cell responses.
    Pérez-Guzmán EX; Pantoja P; Serrano-Collazo C; Hassert MA; Ortiz-Rosa A; Rodríguez IV; Giavedoni L; Hodara V; Parodi L; Cruz L; Arana T; White LJ; Martínez MI; Weiskopf D; Brien JD; de Silva A; Pinto AK; Sariol CA
    Nat Commun; 2019 Sep; 10(1):4316. PubMed ID: 31541110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NS1-Specific Antibody Response Facilitates the Identification of Children With Dengue and Zika in Hyperendemic Areas.
    Castro-Trujillo S; Segura K; Bolívar-Marín S; Salgado DM; Bosch I; Vega R; Rojas MC; Narváez CF
    Pediatr Infect Dis J; 2024 Feb; 43(2):178-185. PubMed ID: 37963312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary infection with dengue or Zika virus does not affect the severity of heterologous secondary infection in macaques.
    Breitbach ME; Newman CM; Dudley DM; Stewart LM; Aliota MT; Koenig MR; Shepherd PM; Yamamoto K; Crooks CM; Young G; Semler MR; Weiler AM; Barry GL; Heimsath H; Mohr EL; Eichkoff J; Newton W; Peterson E; Schultz-Darken N; Permar SR; Dean H; Capuano S; Osorio JE; Friedrich TC; O'Connor DH
    PLoS Pathog; 2019 Aug; 15(8):e1007766. PubMed ID: 31369649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.
    Roth C; Delgado FG; Simon-Lorière E; Sakuntabhai A
    Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29473899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, Virological, and Immunological Profiles of DENV, ZIKV, and/or CHIKV-Infected Brazilian Patients.
    Sánchez-Arcila JC; Badolato-Correa J; de Souza TMA; Paiva IA; Barbosa LS; Nunes PCG; Lima MDRQ; Dos Santos FB; Damasco PV; da Cunha RV; Azeredo EL; de Oliveira-Pinto LM
    Intervirology; 2020; 63(1-6):33-45. PubMed ID: 32966990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary and Secondary Dengue Virus Infections Elicit Similar Memory B-Cell Responses, but Breadth to Other Serotypes and Cross-Reactivity to Zika Virus Is Higher in Secondary Dengue.
    Andrade P; Narvekar P; Montoya M; Michlmayr D; Balmaseda A; Coloma J; Harris E
    J Infect Dis; 2020 Jul; 222(4):590-600. PubMed ID: 32193549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.
    Lim MQ; Kumaran EAP; Tan HC; Lye DC; Leo YS; Ooi EE; MacAry PA; Bertoletti A; Rivino L
    Front Immunol; 2018; 9():2225. PubMed ID: 30327651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of Zika emergence in Latin America on endemic dengue transmission.
    Borchering RK; Huang AT; Mier-Y-Teran-Romero L; Rojas DP; Rodriguez-Barraquer I; Katzelnick LC; Martinez SD; King GD; Cinkovich SC; Lessler J; Cummings DAT
    Nat Commun; 2019 Dec; 10(1):5730. PubMed ID: 31844054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.